Edition:
United States

ConforMIS Inc (CFMS.OQ)

CFMS.OQ on NASDAQ Stock Exchange Global Select Market

1.24USD
13 Jul 2018
Change (% chg)

$0.14 (+12.73%)
Prev Close
$1.10
Open
$1.11
Day's High
$1.31
Day's Low
$1.11
Volume
88,590
Avg. Vol
114,876
52-wk High
$5.72
52-wk Low
$1.08

Chart for

About

ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a... (more)

Overall

Beta: --
Market Cap(Mil.): $185.17
Shares Outstanding(Mil.): 44.84
Dividend: --
Yield (%): --

Financials

  CFMS.OQ Industry Sector
P/E (TTM): -- 32.18 32.76
EPS (TTM): -1.36 -- --
ROI: -51.80 13.91 14.61
ROE: -62.75 16.75 16.34

BRIEF-Conformis Inc Q1 Loss Per Share $0.22

* Q1 EARNINGS PER SHARE VIEW $-0.25 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

May 02 2018

BRIEF-Conformis Q4 Loss Per Share $0.27

* CONFORMIS REPORTS FOURTH QUARTER AND THE YEAR ENDED 2017 FINANCIAL RESULTS; REITERATES 2018 FINANCIAL GUIDANCE

Feb 07 2018

BRIEF-Conformis - Expects Gross Profit Of About $28.8 Mln For Year Ended Dec 31, 2017

* CONFORMIS - GROSS PROFIT EXPECTED TO BE ABOUT $28.8 MILLION OR ABOUT 37% OF REVENUE, FOR YEAR ENDED DECEMBER 31, 2017-SEC FILING

Jan 24 2018

Competitors

Earnings vs. Estimates